Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) just unveiled an announcement.
ResMed Inc. has reported a change in beneficial ownership, with Michael J. Rider, the Global General Counsel, disposing of 64 shares of ResMed common stock at a price of $234.10 per share. This transaction, conducted under a Rule 10b5-1 plan, reflects the company’s ongoing compliance with regulatory requirements and may have implications for its stock market performance and investor relations.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates in the healthcare industry, focusing on the development and manufacturing of equipment related to sleep disorders, respiratory care, and connected health solutions. The company is known for its innovative products that aid in the treatment of sleep apnea and other chronic respiratory conditions, positioning itself as a leader in the global market for medical devices.
YTD Price Performance: 1.17%
Average Trading Volume: 1,026,255
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.08B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.